Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical–pathological features and intratumor heterogeneity over time-Reference-Cited by-同舟云学术

Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical–pathological features and intratumor heterogeneity over time

Published:2018-05 Issue:5 Volume:29 Page:1258-1265
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Pasello G.,Zago G.,Lunardi F.,Urso L.,Kern I.,Vlacic G.,Grosso F.,Mencoboni M.,Ceresoli G.L.,Schiavon M.,Pezzuto F.,Pavan A.,Vuljan S.E.,Del Bianco P.,Conte P.,Rea F.,Calabrese F.

Funder

ESMO

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/29/5/1258/24831828/mdy086.pdf

Reference20 articles.

1. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma;Carbone;Clin Cancer Res,2012

2. Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma;Bograd;Cancer Immunol Immunother,2011

3. CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection;Yamada;Cancer Immunol Immunother,2010